Skip to main contentSkip to navigation
Sirius Investors

QNRX Stock: Quoin Pharmaceuticals, Ltd. Stock Price, Analysis & Insights

Get live qnrx stock price $14.86, comprehensive Quoin Pharmaceuticals, Ltd. stock analysis, charts, news, and expert forecast. Real-time qnrx stock data and investment insights.

14.86
27.51%Today
QNRXQuoin Pharmaceuticals, Ltd. • NASDAQ Capital Market • Healthcare
Market Cap
8.74M
Volume
776.45K
52W High
54.95
52W Low
5.01
Upgrade to Pro or Premium to access long-term historical data (3M, 6M, 1Y, 2Y, 5Y, 10Y, Max)

Company Overview

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.

Company Information

CEO
Michael Myers
Sector
Healthcare
Industry
Biotechnology
Employees
3

Contact Information

Address
42127 Pleasant Forest Court
Country
US

Investment Analysis & Insights

Key Investment Highlights

  • Market Position: Healthcare leader with 8.74M market capitalization
  • Trading Volume: 776.45K shares traded today
  • Price Range: 52-week range of $5.01 - $54.95
  • Exchange: Listed on NASDAQ Capital Market

Financial Metrics

P/E Ratio:0.02
EPS:$958.65
Beta:1.86
Avg Volume:276.08K

Market Analysis for Quoin Pharmaceuticals, Ltd.

Quoin Pharmaceuticals, Ltd. (QNRX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 8.74M, the company represents a significant player in its market. The stock is currently trading at $14.86 with a negativedaily change of 27.51%.

The company's 3 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of 0.02, beta of 1.86, and 52-week price range from $5.01 to $54.95when evaluating investment opportunities.

Why Invest in Quoin Pharmaceuticals, Ltd.?

Strengths
  • • Established market presence in Healthcare
  • • Strong financial metrics and market position
  • • Listed on major exchange (NASDAQ Capital Market)
  • • Experienced leadership under Michael Myers
Investment Considerations
  • • Monitor sector-specific market trends
  • • Track quarterly earnings performance
  • • Consider market volatility and beta
  • • Evaluate long-term growth potential

Related Healthcare Stocks

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.